(Q74598571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Does neuroprotection improve stroke outcome? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

K R Lees

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

9114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

1447-1448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Trials of streptokinase in severe acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978865-6

7 January 2021

10.1016/S0140-6736(05)78865-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9605797%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference